Pandemic Perspectives: Shifting Research Realities After COVID-19 Place Decentralized Trials Center Stage
Varying Stages Of Adoption
Executive Summary
Agreeing that decentralized trials are here to stay, experts discussed in a recent meeting ways in which the pharma research landscape is set to change. With nearly 85% of the industry at different stages of adoption, such trials have seen greater traction in the US, while stricter data privacy laws have hampered progress in Europe, ISCR’s annual conference heard.